The performance was driven by strong growth in the US generics business that saw a 13 percent year on year increase in sales.

Q2 2025 Management View John G. Turner, President and CEO, reported that "Atlas generated $70.5 million of adjusted EBITDA on ...

Archer-Daniels-Midland is in excellent financial health. As of June 30, management reported a net debt/adjusted EBITDA ratio of 2.1 times, which puts the company in a strong financial position. ADM ...

Tariffs are having a bigger impact on Irving-based Caterpillar Inc.’s margins even as demand for the company’s iconic yellow ...

Let’s start with the stock price. BMO shares recently traded at around $154 as of early August 2025. That’s up over 37% from ...

Discover why First Farmers Financial (FFMR) is a Buy with strong financials, local expertise, and 10.5% upside potential ...

Adding red tape to the program that provides health care coverage for low-income families will only make it harder for those ...

The company’s 2025 guidance remains affirmed, but the 2026 adjusted EBITDA outlook was revised down by 2%, a shift from the prior quarter’s unchanged outlook. Strategic focus continues on organic ...

Richer states, mostly in the south and western India, are attracting manufacturing investments in a big way and growing much ...

Microsoft Azure, AWS, Google Cloud earnings results for Q2 2025 total sales, revenue growth, operating income, and global cloud market share.

Small clinics and hospitals are drowning in denied and delayed claims from Illinois Medicaid managed care organizations.